↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "(WFRF:(Bentzen Hans)) srt2:(2005-2009)"

Search: (WFRF:(Bentzen Hans)) > (2005-2009)

Result 1-2 of 2

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Glimelius, Bengt, et al. (author) Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group 2005 In: Acta Oncol. - : Informa UK Limited. - 0284-186X .- 1651-226X. ; 44:8, s. 904-12 Journal article (peer-reviewed)abstract Due to uncertainties regarding clinically meaningful gains from adjuvant chemotherapy after colorectal cancer surgery, several Nordic Groups in the early 1990s initiated randomised trials to prove or reject such gains. This report gives the joint analyses after a minimum 5-year follow-up. Between October 1991 and December 1997, 2 224 patients under 76 years of age with colorectal cancer stages II and III were randomised to surgery alone (n = 1 121) or adjuvant chemotherapy (n = 1 103) which varied between trials (5FU/levamisole for 12 months, n = 444; 5FU/leucovorin for 4-5 months according to either a modified Mayo Clinic schedule (n = 262) or the Nordic schedule (n = 397). Some centres also randomised patients treated with 5FU/leucovorin to+/-levamisole). A total of 812 patients had colon cancer stage II, 708 colon cancer stage III, 323 rectal cancer stage II and 368 rectal cancer stage III. All analyses were according to intention-to-treat. No statistically significant difference in overall survival, stratified for country or region, could be found in any group of patients according to stage or site. In colon cancer stage III, an absolute difference of 7% (p = 0.15), favouring chemotherapy, was seen. The present analyses corroborate a small but clinically meaningful survival gain from adjuvant chemotherapy in colon cancer stage III, but not in the other presentations.
2.	Kolstad, Arne, et al. (author) (90)y-Ibritumumab Tiuxetan (Zevalin (R))-BEAM/C with Autologous Stem Cell Support as Frontline Therapy for Advanced Mantle Cell Lymphoma.- Preliminary Results From the Third Nordic MCL Phase II Study (MCL3) 2009 In: Blood. - 1528-0020 .- 0006-4971. ; 114:22, s. 384-384 Conference paper (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-2 of 2

Refine your search

Type of publication: conference paper (1); journal article (1)

Type of content: peer-reviewed (2)

Author/Editor: Glimelius, Bengt (1); Jerkeman, Mats (1); Hultborn, Ragnar, 19 ... (1); Nilsson-Ehle, Herman (1); Geisler, Christian H (1); Laurell, Anna (1); show more...; Cedermark, B (1); Pedersen, Lone Bredo (1); Albertsson, Maria (1); Gronberg, H (1); Ehinger, Mats (1); Kolstad, Arne (1); Raty, Riikka (1); Ralfkiaer, Elisabeth (1); Karjalainen-Lindsber ... (1); Dahl, O. (1); Andersen, Niels S. (1); Elonen, Erkki (1); Lauritzsen, Grete F. (1); Nordstrom, Marie (1); Loft, Annika (1); Bogsrud, Trond Velde (1); Hansen, Per Boye (1); Fagerli, Unn-Merete (1); Lehmann, Anne Kristi ... (1); Delabie, Jan (1); Bentzen, Hans (1); Sundstrom, Christer (1); Jakobsen, A (1); Pahlman, Lars (1); Starkhammar, Hans, 1 ... (1); Meyer, Peter (1); Bentzen, S. M. (1); Tveit, K. M. (1); Gillstrom, Dorte (1); show less...

University: Lund University (2); Karolinska Institutet (2); University of Gothenburg (1); Umeå University (1); Uppsala University (1); Linköping University (1)

Language: English (2)

Research subject (UKÄ/SCB): Medical and Health Sciences (2)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view